Carpenter, A
Characterization of human cytochrome P450 mediated bioactivation of amodiaquine and its major metabolite N-desethylamodiaquine
Laboratory studies have demonstrated biological activity at concentrations as low as 0.01 nanomolar, showing measurable effects on fibroblast activity and collagen production even at these minute levels
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157 in rats and dogs
For patients who are not well-controlled on a treatment with metformin and basal insulin, a treatment intensification with a DPP-4 inhibitor may be feasible
Kevin Jones, MD Board Certified Obesity Medicine Physician Flow Wellness GLP-1 Support in California, Oregon, and Washington At Flow Wellness, we help patients understand every aspect of their GLP-1 treatment program, including medication dosing, side effect management, nutrition, and long-term success strategies